DOPATREEPreview
Open in TheBrain

US FDA. DRAFT GUIDANCE. POTENCY ASSAY CONSIDERATIONS FOR MONOCLONAL ANTIBODIES AND OTHER THERAPEUTIC PROTEINS TARGETING VIRAL PATHOGENS. MAR 2023.

Attachments